Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Cirella

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and ImmunotherapyAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Pharmacology & Therapeutics|April 17, 2022
Novel strategies exploiting interleukin-12 in cancer immunotherapyAssunta Cirella, Carlos Luri-Rey, Claudia Augusta Di Trani, et al.
EMBO Molecular Medicine|October 2, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodiesIgnacio Melero, Maria C Ochoa, Carmen Molina, et al.
Cell Reports. Medicine|April 11, 2023
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinomaMaria Carmen Ochoa, Sandra Sanchez-Gregorio, Carlos E de Andrea, et al.
European Journal of Immunology|May 8, 2021
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophilsAlvaro Teijeira, Saray Garasa, Maria Del Carmen Ochoa, et al.
Oncoimmunology|December 19, 2022
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8<sup>+</sup> T cells eradicates peritoneal metastases in mouse modelsClaudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Cancer Research|September 21, 2022
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy EfficacyAlvaro Teijeira, Saray Garasa, Carlos Luri-Rey, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology|April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimeticMaite Alvarez, Carmen Molina, Saray Garasa, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and ImmunotherapyAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Pharmacology & Therapeutics|April 17, 2022
Novel strategies exploiting interleukin-12 in cancer immunotherapyAssunta Cirella, Carlos Luri-Rey, Claudia Augusta Di Trani, et al.
EMBO Molecular Medicine|October 2, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodiesIgnacio Melero, Maria C Ochoa, Carmen Molina, et al.
Cell Reports. Medicine|April 11, 2023
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinomaMaria Carmen Ochoa, Sandra Sanchez-Gregorio, Carlos E de Andrea, et al.
European Journal of Immunology|May 8, 2021
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophilsAlvaro Teijeira, Saray Garasa, Maria Del Carmen Ochoa, et al.
Oncoimmunology|December 19, 2022
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8<sup>+</sup> T cells eradicates peritoneal metastases in mouse modelsClaudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Cancer Research|September 21, 2022
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy EfficacyAlvaro Teijeira, Saray Garasa, Carlos Luri-Rey, et al.
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology|April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimeticMaite Alvarez, Carmen Molina, Saray Garasa, et al.
Pageof 3